In the Clinic Dyslipidemia

被引：57
作者：
Arvanitis, Marios [1 ]
Lowenstein, Charles J. [1 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2023年 / 176卷 / 06期
关键词：
DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; FOLLOW-UP; RISK; MANAGEMENT; STATINS; SAFETY; WOMEN;
D O I：
10.7326/AITC202306200
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Dyslipidemia is an important risk factor for coronary artery disease and stroke. All persons with dyslipidemia should be advised to focus on lifestyle interventions, including regular aerobic exercise, a healthy diet, maintenance of a healthy weight, and abstinence from smoking. In addition to lifestyle interventions, lipid-lowering therapy should be considered for persons at moderate to high risk for atherosclerotic cardiovascular disease based on validated risk equations. Statin therapy is the first-line medical treatment for dyslipidemia due to its effectiveness and favorable adverse effect profile, but newer treatments provide additional tools for clinicians to effectively treat dyslipidemia.
引用
收藏
页码：ITC81 / U191
页数：17
相关论文
共 54 条
  • [41] Triglycerides and the risk of coronary heart disease - 10 158 incident cases among 262 525 participants in 29 Western prospective studies
    Sarwar, Nadeem
    Danesh, John
    Eiriksdottir, Gudny
    Sigurdsson, Gunnar
    Wareham, Nick
    Bingham, Sheila
    Boekholdt, S. Matthijs
    Khaw, Kay-Tee
    Gudnason, Vilmundur
    [J]. CIRCULATION, 2007, 115 (04) : 450 - 458
  • [42] Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
    Schwartz, G. G.
    Steg, P. G.
    Szarek, M.
    Bhatt, D. L.
    Bittner, V. A.
    Diaz, R.
    Edelberg, J. M.
    Goodman, S. G.
    Hanotin, C.
    Harrington, R. A.
    Jukema, J. W.
    Lecorps, G.
    Mahaffey, K. W.
    Moryusef, A.
    Pordy, R.
    Quintero, K.
    Roe, M. T.
    Sasiela, W. J.
    Tamby, J. -F.
    Tricoci, P.
    White, H. D.
    Zeiher, A. M.
    Aylward, Philip E.
    Drexel, Heinz
    Sinnaeve, Peter
    Dilic, Mirza
    Lopes, Renato D.
    Gotcheva, Nina N.
    Goodman, Shaun G.
    Prieto, Juan-Carlos
    Yong, Huo
    Lopez-Jaramillo, Patricio
    Pecin, Ivan
    Reiner, Zeljko
    Ostadal, Petr
    Poulsen, Steen Hvitfeldt
    Viigimaa, Margus
    Nieminen, Markku S.
    Danchin, Nicolas
    Chumburidze, Vakhtang
    Marx, Nikolaus
    Liberopoulos, Evangelos
    Montenegro Valdovinos, Pablo Carlos
    Tse, Hung-Fat
    Kiss, Robert Gabor
    Xavier, Denis
    Zahger, Doron
    Valgimigli, Marco
    Kimura, Takeshi
    Kim, Hyo Soo
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (22) : 2097 - 2107
  • [43] Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
    Schwartz, Gregory G.
    Olsson, Anders G.
    Abt, Markus
    Ballantyne, Christie M.
    Barter, Philip J.
    Brumm, Jochen
    Chaitman, Bernard R.
    Holme, Ingar M.
    Kallend, David
    Leiter, Lawrence A.
    Leitersdorf, Eran
    McMurray, John J. V.
    Mundl, Hardi
    Nicholls, Stephen J.
    Shah, Prediman K.
    Tardif, Jean-Claude
    Wright, R. Scott
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (22) : 2089 - 2099
  • [44] Comparison of the Framingham Risk Score, SCORE and WHO/ISH cardiovascular risk prediction models in an Asian population
    Selvarajah, Sharmini
    Kaur, Gurpreet
    Haniff, Jamaiyah
    Cheong, Kee Chee
    Hiong, Tee Guat
    van der Graaf, Yolanda
    Bots, Michiel L.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 176 (01) : 211 - 218
  • [45] Apolipoprotein B Particles and Cardiovascular Disease A Narrative Review
    Sniderman, Allan D.
    Thanassoulis, George
    Glavinovic, Tamara
    Navar, Ann Marie
    Pencina, Michael
    Catapano, Alberico
    Ference, Brian A.
    [J]. JAMA CARDIOLOGY, 2019, 4 (12) : 1287 - 1295
  • [46] Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol
    Stein, Evan A.
    Mellis, Scott
    Yancopoulos, George D.
    Stahl, Neil
    Logan, Douglas
    Smith, William B.
    Lisbon, Eleanor
    Gutierrez, Maria
    Webb, Cheryle
    Wu, Richard
    Du, Yunling
    Kranz, Therese
    Gasparino, Evelyn
    Swergold, Gary D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (12) : 1108 - 1118
  • [47] 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
    Stone, Neil J.
    Robinson, Jennifer G.
    Lichtenstein, Alice H.
    Merz, C. Noel Bairey
    Blum, Conrad B.
    Eckel, Robert H.
    Goldberg, Anne C.
    Gordon, David
    Levy, Daniel
    Lloyd-Jones, Donald M.
    McBride, Patrick
    Schwartz, J. Sanford
    Shero, Susan T.
    Smith, Sidney C., Jr.
    Watson, Karol
    Wilson, Peter W. F.
    [J]. CIRCULATION, 2014, 129 (25) : S1 - S45
  • [48] Lipoprotein(a) Reduction in Persons with Cardiovascular Disease
    Tsimikas, Sotirios
    Karwatowska-Prokopczuk, Ewa
    Gouni-Berthold, Ioanna
    Tardif, Jean-Claude
    Baum, Seth J.
    Steinhagen-Thiessen, Elizabeth
    Shapiro, Michael D.
    Stroes, Erik S.
    Moriarty, Patrick M.
    Nordestgaard, Borge G.
    Xia, Shuting
    Guerriero, Jonathan
    Viney, Nicholas J.
    O'Dea, Louis
    Witztum, Joseph L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (03) : 244 - 255
  • [49] U.S. Food and Drug Administration, 2023, FDA REQ REM STRONG
  • [50] US Food and Drug Administration, 2023, FDA DRUG SAFETY COMM
123456